• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 27-Sep-2022 EOD, Market Closed
SENSEX
57,107.52
-37.70 (-0.07%)
NIFTY
17,007.40
-8.90 (-0.05%)
    No Companies Visited

Board Meeting

Announcement Date Date of Meeting Purpose
12-Jul-2022 29-Jul-2022 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2022 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2022 With reference to the intimation of Board meeting submitted on July 12, 2022, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. July 29, 2022 which commenced at 10:00 a.m. IST and ended at 01:25 p.m. IST. The Board has, inter-alia, approved Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2022. (As per BSE Announcement Dated on 29/07/2022)
12-May-2022 30-May-2022 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve i. Annual Audited Standalone and Consolidated Financial Results; and ii. Recommendation of final dividend if any. Attached (As Per BSE Announcement dated on 30.05.2022)
17-Jan-2022 31-Jan-2022 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2022 inter alia to consider and approve This is to inform you that the meeting of the Board of Directors of the Company will be held on Monday January 31 2022 to inter alia consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2021. Further kindly note that pursuant to the Companys Code of Conduct for Prevention of Insider Trading the window closure for trading by Designated Persons commenced on January 01 2022 and shall end on February 02 2022 i.e. after 48 hours of the declaration of financial results of the Company on January 31 2022. This is for your information and dissemination. This is to inform you that the Board of Directors of the Company, at its meeting scheduled to be held on Monday, January 31, 2022, will inter-alia consider declaration of Interim Dividend on the equity shares of the Company, for the financial year 2021-22. (As Per BSE Announcement dated on 25.01.2022) As per the letter attached (As per BSE Announcement Dated on 31/01/2022) Sun Pharmaceutical Industries Ltd has informed BSE that the Company has fixed February 10, 2022 as the Record Date for the purpose of Payment of Interim Dividend. The payment of the interim dividend would be made to the eligible shareholders on or before February 22, 2022. (As Per BSE Announcement dated on 01.02.2022)
12-Oct-2021 02-Nov-2021 Quarterly Results SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2021 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, November 02, 2021 to inter alia consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021. Further, kindly note that pursuant to the Company''s Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on October 01, 2021, and shall end on November 04, 2021 i.e. after 48 hours of the declaration of financial results of the Company on November 02, 2021. This is for your information and dissemination. The Board of Directors of the Company at its meeting held today i.e. November 02, 2021 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we enclose herewith the following as 'Annexure': a) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021. b) Limited Review Report of the Statutory Auditors of the Company on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021. The meeting of the Board of Directors of the Company commenced at 10:30 a.m. and concluded at 01:10 p.m. (As Per BSE Announcement Dated 02.11.2021)
13-Jul-2021 30-Jul-2021 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2021 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2021 The Board of Directors of the Company at its meeting held today i.e. July 30, 2021 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2021. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we enclose herewith the following as 'Annexure': a) Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended June 30, 2021. b) Limited Review Report of the Statutory Auditors of the Company on Unaudited (Standalone and Consolidated) Financial Results for the quarter ended June 30, 2021. The meeting of the Board of Directors of the Company commenced at 10.15 a.m. and concluded at 1:45 p.m. (As per BSE Announcement Dated on 30/07/2021)
10-May-2021 27-May-2021 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve (i) Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2021. (ii) recommendation of final dividend for the year ended March 31, 2021 subject to the approval of the shareholders at the ensuing 29th Annual General Meeting. As per letter attached (As Per BSE Announcement dated on 27.05.2021)
04-Jan-2021 29-Jan-2021 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2021 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company will be held on Friday, January 29, 2021 to inter alia consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2020. Further, kindly note that pursuant to the Company''s Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on January 01, 2021, and shall end on January 31, 2021 i.e. after 48 hours of the declaration of financial results of the Company on January 29, 2021. This is for your information and record. The Board of Directors of the Company, at its meeting scheduled to be held on Friday, January 29, 2021, will inter-alia consider declaration of Interim Dividend on the equity shares of the Company, for the financial year 2020-21 (AS Per BSE Announcement Dated on 21.01.2021) 1)Approval of Unaudited Financial Statements for the quarter and nine months ended December 31, 2020; 2) Declaration of an Interim Dividend for the financial year ending on March 31, 2021 and fixing of Record Date for the same; and 3) Re-appointment of Mr. Kalyanasundaram Subramanian (DIN: 00179072) as Whole-time Director for further period of two years w.e.f. February 14, 2021. The Board at its meeting held today, declared an interim dividend of Rs. 5.50/- (Rupees Five and paise fifty only) per equity share of Re. 1/- each of the Company for the financial year ending on March 31, 2021. Further, the Board of Directors of the Company has fixed Wednesday, February 10, 2021 as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive payment towards Interim Dividend of the Company for the financial year 2020-21 declared today. The payment of the interim dividend would be made to the eligible shareholders on or before February 19, 2021. 1) Approval of Unaudited Financial Statements for the quarter and nine months ended December 31, 2020; 2) Declaration of an Interim Dividend for the financial year ending on March 31, 2021 and fixing of Record Date for the same; and 3) Re-appointment of Mr. Kalyanasundaram Subramanian (DIN: 00179072) as Whole-time Director for further period of two years w.e.f. February 14, 2021. The Board at its meeting held today, declared an interim dividend of Rs. 5.50/- (Rupees Five and paise fifty only) per equity share of Re. 1/- each of the Company for the financial year ending on March 31, 2021. Further, the Board of Directors of the Company has fixed Wednesday, February 10, 2021 as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive payment towards Interim Dividend of the Company for the financial year 2020-21 declared today. The payment of the interim dividend would be made to the eligible shareholders on or before February 19, 2021. (As Per BSE Announcement Dated on 1/29/2021)
21-Oct-2020 03-Nov-2020 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020. The Board of Directors of the Company at its meeting held today i.e. November 03, 2020 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2020. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we enclose herewith the following as 'Annexure': a) Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2020. b) Limited Review Report of the Statutory Auditors of the Company on Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2020. The meeting of the Board of Directors of the Company commenced at 10:30 a.m. and concluded at 02:40 p.m. (AS Per BSE Announcement Dated on 03.11.2020)
22-Jul-2020 31-Jul-2020 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company will be held on Friday, July 31, 2020, interalia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2020. Further, kindly note that pursuant to the Company''s Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on July 01, 2020, and shall end on August 02, 2020.
18-May-2020 27-May-2020 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2020 ,inter alia, to consider and approve (i) To consider and approve Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2020. (ii) To consider recommendation of final dividend for the year ended March 31, 2020 subject to the approval of the shareholders at the ensuing Annual General Meeting. As per file attached (As Per BSE Announcement Dated on 27.05.2020)
1 2 3  Next 

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
9769005430
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 27-Sep-2022
  •  ( 15:50) Sensex, Nifty end flat after volatile session; oil & gas shares advance  
  •  ( 15:45) ICRA revises outlook on CMS Info Systems' rating to 'positive'  
  •  ( 15:40) Inox Wind commissions project in Gujarat  
  •  ( 14:36) Exide Inds commences work on lithium-ion cell manufacturing facility  
  •  ( 13:31) Nifty tad above 17,100; Sensex adds 332 pts; European stocks rise  
  •  ( 13:29) HFCL bags purchase orders worth Rs 202.60 crore  
  •  ( 13:09) GPT Infraprojects board OKs 1:1 bonus issue  
  •  ( 12:33) Oil & gas stocks advance  
  •  ( 12:32) Benchmarks trade with minor gains  
  •  ( 12:06) EKI Energy arm completes capacity expansion project in Maharashtra  
  •  ( 11:36) Indices trade almost flat, Metal stocks lose shine  
  •  ( 11:14) Optiemus Infracom arm partners with Dizo  
  •  ( 11:07) Shakti Pumps receives $6 mn advance for Uganda project  
  •  ( 10:48) Manappuram Finance board to mull debt issue in Oct'22  
  •  ( 10:36) Indices trim gains, Nifty below 17,050 mark, FMCG shares advance  
  •  ( 10:27) Orient Bell completes capex plan before schedule  
  •  ( 09:48) Jyoti Structures wins 237-cr order  
  •  ( 09:33) Market drifts higher in early trade; breadth strong  
  •  ( 09:27) STL divests stake in UK-based Impact Data Solutions  
  •  ( 09:23) Aarti Drugs reappoints Rashesh Gogri as MD for 5 years  
  •  ( 09:19) Mahindra Logistics acquires Rivigo's B2B express biz  
  •  ( 08:44) Asian stocks trading mixed  
  •  ( 08:25) U.S. stocks end mixed on global growth worries, rate fears  
Show News
27 September 2022 00:00
3470.40
(0.94 %)
737.30
(-0.69 %)
7240.90
(-0.20 %)
1679.65
(0.13 %)
760.60
(0.72 %)
4182.10
(1.20 %)
2290.15
(-0.83 %)
918.25
(1.25 %)
1414.35
(-0.76 %)
2678.95
(0.59 %)
852.85
(-0.96 %)
1164.40
(1.32 %)
1392.20
(0.90 %)
334.85
(0.69 %)
1801.25
(-1.52 %)
1840.10
(-0.60 %)
1235.75
(0.04 %)
8772.65
(-0.66 %)
18674.80
(1.19 %)
159.10
(0.35 %)
204.90
(1.81 %)
2395.40
(0.75 %)
536.25
(-1.39 %)
896.90
(-0.06 %)
97.60
(-2.25 %)
3018.65
(0.80 %)
1022.50
(-1.08 %)
2597.25
(-2.16 %)
6198.10
(0.35 %)
398.15
(0.86 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.